Canada - English - Health Canada

cobalt pharmaceuticals company - bromocriptine (bromocriptine mesylate) - capsule - 5mg - bromocriptine (bromocriptine mesylate) 5mg - ergot-derivative dopamine receptor agonists

Canada - English - Health Canada

cobalt pharmaceuticals company - bromocriptine (bromocriptine mesylate) - tablet - 2.5mg - bromocriptine (bromocriptine mesylate) 2.5mg - ergot-derivative dopamine receptor agonists

Canada - English - Health Canada

novartis pharmaceuticals canada inc - bromocriptine (bromocriptine mesylate) - tablet - 2.5mg - bromocriptine (bromocriptine mesylate) 2.5mg - ergot-derivative dopamine receptor agonists

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - bromocriptine mesilate -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - bromocriptine mesilate -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - bromocriptine mesilate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - bromocriptine mesilate, quantity: 2.87 mg (equivalent: bromocriptine, qty 2.5 mg) - tablet, uncoated - excipient ingredients: maize starch; lactose monohydrate; disodium edetate; colloidal anhydrous silica; maleic acid; magnesium stearate - prevention of onset of lactation in the puerperium for clearly defined medical reasons. therapy should be continued for 14 days to prevent rebound lactation. parlodel should not be used to suppress established lactation. treatment of hyperprolactinaemia where surgery and/or radiotherapy are not indicated or have already been used with incomplete resolution. precautions should be taken to ensure that the hyperprolactinaemia is not due to severe primary hypothyroidism. where the cause of hyperprolactinaemia is a prolactin-secreting microadenoma or macroadenoma, parlodel is indicated for conservative treatment; prior to surgery in order to reduce tumour size and to facilitate removal; after surgery if prolactin level is still elevated. adjunctive therapy in the management of acromegaly when: (1) the patient refuses surgery and/or radiotherapy; (2) surgery and/or radiotherapy has been unsuccessful or full effects are not expected for some months; (3) a manifestation of the acromegaly needs to be brought under con

Malta - English - Malta Medicines Authority

meda pharmaceuticals limited - bromocriptine - tablet - bromocriptine 2.5 mg - other gynecologicals

Malta - English - Malta Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - bromocriptine - tablet - bromocriptine 2.5 mg - anti-parkinson drugs

Malta - English - Malta Medicines Authority

generics uk limited station close, potters bar, herts, en6 1tl, united kingdom - bromocriptine mesilate - tablet - bromocriptine mesilate 2.5 mg - other gynecologicals